Updated:
Medison Pharma
Medison Pharma is a pharmaceutical company founded in 1996 in Petah Tikva, Israel. It operates within the biotech and pharmaceutical sectors, providing...
Medison Pharma
Medison Pharma is a pharmaceutical company founded in 1996 in Petah Tikva, Israel. It operates within the biotech and pharmaceutical sectors, providing services such as regulatory expertise, market access, and distribution solutions. The company serves the biotech industry, supporting the launch and commercialization of therapies in international markets.
General information
Firm type
Asset Manager
Year founded
1995
Location
Region
Middle East
Country
Israel
City
Petah Tikva
Corporate office
Petah Tikva, Israel
Additional offices
Herzliya, Israel · Guangzhou, China · Somerville, MA, United States · Vancouver, Canada
Principals
Morris C. Laster
Founder and Chairman
Sector focus
Frequently asked questions
How does Medison Pharma source proprietary deal flow?
Medison sources deals through direct relationships with biotech firms seeking market access outside their home regions. The firm's track record in regulatory approval and commercialization in Israel, China, and other markets acts as a differentiator, attracting partners who need a reliable local partner.
What investment stages does Medison Pharma typically target?
Medison focuses on late-stage therapeutics—drugs that have completed or are nearing completion of clinical trials and have regulatory approval in at least one major market. The firm avoids early-stage R&D risk, instead specializing in commercial execution.
Which sectors does Medison Pharma explicitly avoid?
Medison does not publicly state excluded sectors, but by its nature it avoids medical devices, diagnostics, and early-stage discovery biotech. Its focus is on approved or near-approved pharmaceutical products, primarily in oncology, rare disease, and specialty therapeutics.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: